活血消瘿膏治疗痰结血瘀型甲状腺结节临床研究OA
Clinical Study on Huoxue Xiaoying Soft Extract for Thyroid Nodules of Phlegm Coagulation and Blood Stasis Type
目的:观察活血消瘿膏治疗痰结血瘀型甲状腺结节的临床疗效.方法:选取2023年10月—2025年5月于深圳市宝安区中医院内分泌科门诊就诊的痰结血瘀型甲状腺结节患者100例作为研究对象,采用随机数字表法将受试者按1∶1比例分为治疗组和对照组各50例.对照组实施常规生活方式管理,治疗组在对照组的基础上加用活血消瘿膏口服.2组均持续干预12周.比较2组临床疗效及安全性,以及治疗前后中医证候评分、甲状腺结节最大径大小、甲状腺功能[促甲状腺激素(TSH)、游离甲状腺素(FT4)、游离三碘甲状腺原氨酸(FT3)]的变化.结果:治疗后,治疗组总有效率为84.00%(42/50),对照组为16.00%(8/50),2组比较,差异有统计学意义(P<0.05).治疗后,治疗组中医证候评分较治疗前降低(P<0.05),且治疗组评分低于对照组(P<0.05);对照组中医证候评分治疗前后比较,差异无统计学意义(P>0.05).治疗后,治疗组甲状腺结节最大径较治疗前缩小(P<0.05),且治疗组结节最大径小于对照组(P<0.05);对照组甲状腺结节最大径治疗前后比较,差异无统计学意义(P>0.05).治疗后,治疗组甲状腺结节改善率为62.00%(31/50),对照组为4.00%(2/50),2组比较,差异有统计学意义(P<0.05).治疗前后,2组甲状腺功能指标血清TSH、FT3、FT4水平比较,差异均无统计学意义(P>0.05).治疗期间,2组均无明显不良反应.结论:活血消瘿膏治疗甲状腺结节具有一定的临床优势,能有效改善中医证候、缓解临床症状,缩小甲状腺结节最大径,且治疗安全性良好.
Objective:To observe the clinical efficacy of Huoxue Xiaoying Soft Extract in treating thyroid nodules of phlegm coagulation and blood stasis type.Methods:A total of 100 patients with thyroid nodules of phlegm coagulation and blood stasis type who attended the outpatient clinic of the Department of Endocrinology,Shenzhen Bao'an Traditional Chinese Medicine Hospital from October 2023 to May 2025 were enrolled in this study.Using a random number table method,the participants were divided into a treatment group and a control group at a 1∶1 ratio,with 50 cases in each group.The control group received conventional lifestyle management,while the treatment group received oral Huoxue Xiaoying Soft Extract in addition to the lifestyle management.Both groups received continuous intervention for 12 weeks.The clinical efficacy and safety were compared between the two groups,as well as changes in traditional Chinese medicine syndrome scores,maximum diameter of thyroid nodules,and thyroid function[thyroid-stimulating hormone(TSH),free thyroxine(FT4),free triiodothyronine(FT3)]before and after treatment.Results:After treatment,the total effective rate was 84.00%(42/50)in the treatment group and 16.00%(8/50)in the control group,with a statistically significant difference between the two groups(P<0.05).After treatment,traditional Chinese medicine syndrome scores in the treatment group decreased compared to before treatment(P<0.05),and the scores in the treatment group were lower than those in the control group(P<0.05);there was no statistically significant difference in traditional Chinese medicine syndrome scores in the control group before and after treatment(P>0.05).After treatment,the maximum diameter of thyroid nodules in the treatment group decreased compared to before treatment(P<0.05),and the maximum nodule diameter in the treatment group was smaller than that in the control group(P<0.05);there was no statistically significant difference in the maximum diameter of thyroid nodules in the control group before and after treatment(P>0.05).After treatment,the improvement rate of thyroid nodules was 62.00%(31/50)in the treatment group and 4.00%(2/50)in the control group,with a statistically significant difference between the two groups(P<0.05).Before and after treatment,there were no statistically significant differences in serum levels of TSH,FT3,and FT4 between the two groups(P>0.05).During the treatment period,no significant adverse reactions were observed in either group.Conclusion:Huoxue Xiaoying Soft Extract can effectively improve traditional Chinese medicine syndrome,alleviate clinical symptoms,and reduce the maximum diameter of thyroid nodules with good safety in treating thyroid nodules.
李秋逸;陈可欣;张越;许帅;郭叙喜;叶仁群
广州中医药大学第七临床医学院,广东 深圳 518133广州中医药大学第七临床医学院,广东 深圳 518133深圳市宝安区中医院内分泌科,广东 深圳 518133深圳市宝安区中医院内分泌科,广东 深圳 518133深圳市宝安区中医院内分泌科,广东 深圳 518133深圳市宝安区中医院内分泌科,广东 深圳 518133
医药卫生
甲状腺结节痰结血瘀型活血消瘿膏结节最大径甲状腺功能
Thyroid nodulesPhlegm coagulation and blood stasis typeHuoxue Xiaoying Soft ExtractMaximum nodule diameterThyroid function
《新中医》 2026 (10)
29-34,6
广东省中医药局科研项目(20241272)广东省深圳市宝安区科技创新局项目(2023JD128)湖北陈孝平科技发展基金会慢病药学及临床管理高质量发展专项基金(CXPJJH125009-04)
评论